Comparison of ICRU 38 rectal reference point dose estimates with measured dose in vivo in cobalt-60 HDR brachytherapy for cervical cancer
- 8 May 2020
- journal article
- research article
- Published by Springer Nature in Journal of Radiation Oncology
- Vol. 9 (1-2) , 37-43
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancerPhysica Medica, 2014
- American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapyBrachytherapy, 2012
- A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancerJournal of Medical Imaging and Radiation Oncology, 2011
- Use of Normal Tissue Complication Probability Models in the ClinicInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: Correlation and comparison with published Vienna applicator dataBrachytherapy, 2008
- Comparison of 60Cobalt and 192Iridium Sources in High Dose Rate Afterloading BrachytherapyStrahlentherapie und Onkologie, 2008
- Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervixInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000